The expanding field of targeted treatment relies heavily on recombinant growth factor technology, and a thorough understanding of individual profiles is absolutely crucial for fine-tuning experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 reveals notable differences in th